Historical shareholding details of
Emerald Advisers, LLC
holdings in Blueprint Medicines Corp (BPMC)
Monthly changes of
Emerald Advisers, LLC
shareholding in Blueprint Medicines Corp
over the previous
months
Month
|
Name |
Total no. shares held |
Percent Holding |
Mar 31, 2025
|
Emerald Advisers, Llc
|
35,973
|
0.06%
|
|
Feb 28, 2025
|
Emerald Advisers, Llc
|
35,973
|
0.06%
|
|
Jan 31, 2025
|
Emerald Advisers, Llc
|
35,973
|
0.06%
|
|
Dec 31, 2024
|
Emerald Advisers, Llc
|
416,866
|
0.65%
|
Dec 31, 2024
|
Emerald Advisers, Llc
|
35,973
|
0.06%
|
|
Nov 30, 2024
|
Emerald Advisers, Llc
|
35,349
|
0.06%
|
|
Oct 31, 2024
|
Emerald Advisers, Llc
|
31,748
|
0.05%
|
|
Sep 30, 2024
|
Emerald Advisers, Llc
|
375,866
|
0.59%
|
Sep 30, 2024
|
Emerald Advisers, Llc
|
31,748
|
0.05%
|
|
Aug 31, 2024
|
Emerald Advisers, Llc
|
31,492
|
0.05%
|
|
Jul 31, 2024
|
Emerald Advisers, Llc
|
28,260
|
0.04%
|
|
Jun 30, 2024
|
Emerald Advisers, Llc
|
341,200
|
0.54%
|
Jun 30, 2024
|
Emerald Advisers, Llc
|
27,354
|
0.04%
|
|
May 31, 2024
|
Emerald Advisers, Llc
|
27,781
|
0.04%
|
|
Apr 30, 2024
|
Emerald Advisers, Llc
|
34,341
|
0.05%
|
|
Mar 31, 2024
|
Emerald Advisers, Llc
|
402,910
|
0.64%
|
Mar 31, 2024
|
Emerald Advisers, Llc
|
34,341
|
0.06%
|
|
Feb 29, 2024
|
Emerald Advisers, Llc
|
35,175
|
0.06%
|
|
Jan 31, 2024
|
Emerald Advisers, Llc
|
35,175
|
0.06%
|
|
Dec 31, 2023
|
Emerald Advisers, Llc
|
466,426
|
0.74%
|
Dec 31, 2023
|
Emerald Advisers, Llc
|
48,245
|
0.08%
|
|
Nov 30, 2023
|
Emerald Advisers, Llc
|
48,245
|
0.08%
|
|
Oct 31, 2023
|
Emerald Advisers, Llc
|
48,245
|
0.08%
|
|
Sep 30, 2023
|
Emerald Advisers, Llc
|
607,037
|
1.00%
|
Sep 30, 2023
|
Emerald Advisers, Llc
|
42,237
|
0.07%
|
|
Aug 31, 2023
|
Emerald Advisers, Llc
|
39,955
|
0.07%
|
|
Jul 31, 2023
|
Emerald Advisers, Llc
|
39,955
|
0.07%
|
|
Jun 30, 2023
|
Emerald Advisers, Llc
|
496,053
|
0.82%
|
Jun 30, 2023
|
Emerald Advisers, Llc
|
39,333
|
0.07%
|
|
May 31, 2023
|
Emerald Advisers, Llc
|
33,695
|
0.06%
|
|
Mar 31, 2023
|
Emerald Advisers, Llc
|
438,249
|
0.72%
|
View all ownership details of Blueprint Medicines Corp